◆ 会议时间:2024年5月5日至7日
◆ 会议地点:美国 菲尼克斯
◆ 会议简介:
2024年第28届美国远程医疗协会(ATA)年会将于2024年5月5日至7日在美国菲尼克斯举行。美国远程医疗协会年会暨展览会世界最大的远程医疗综合性会议,是远程医疗、数字医疗、移动医疗领域内的医学人士及企业家们的重要论坛。每年年会都有数千名来自传统医学、学术医疗中心、电信科技公司、电子医疗、医学会、政府及其他相关组织的与会者参加此次大会。
美国远程医疗协会(ATA)成立于1993年,是一家拥有超过10000名行业领导者和医疗保健专人士会员的非营利性协会,是全球领先世界最大的远程医疗协会,总部设立于华盛顿特区。ATA旨在团结传统医学、学术医学中心、电信科技公司、政府机构宣等不同组织,倡导远程医疗理念,改善世界医疗质量,提高远程医疗技术水平,以降低综合医疗成本。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
ATA2024 - 28th Annual Conference & Expo of the American Telemedicine Association
Date: March 5-7, 2024
Venue: PHOENIX, AZ, USA
注册费:
|
EARLY BIRD PRICING
(Open thru Feb 1) |
STANDARD
(After Feb 1) |
MEMBER |
$1,295 |
$1,395 |
NON-MEMBER |
$1,495 |
$1,595 |
GOVERNMENT |
$725 |
$725 |
STUDENT/ACADEMIC
|
$350 |
$350 |
IN-PERSON: All Access
Highest level of access to include:
- All live content (deep-dive sessions, mainstage sessions, concurrent sessions)
- All pre-recorded content
- Floor presentations and online exhibitor listings
- Monday night Social
- Meals (Breakfast, Lunch and breaks during Conference)
- On Demand access to recorded sessions post-conference
Cancellation / Refund Policy
- ATA2024 offers three levels of registration: In-Person All Access, Exhibits Plus and On Demand. In-Person All Access will receive a Map Your Show account to access exhibitor listings, and for All Access and On Demand
registration, access to recorded on-demand sessions. All sessions will be recorded and available as on demand.
- A registrant can upgrade registration from On Demand to All Access In-Person by paying the difference in registration fee.
- A registrant can downgrade registration from All Access In-person to On Demand, however no refund of difference in price will be provided.
- If you are unsure if you will be attending ATA2024 in-person, we suggest that you register for On Demand and upgrade at a later time if you decide to attend in-person.
All requests for refunds for cancellations received prior to January 7, 2024, will be honored, less a $100 administrative fee. Refund requests must be sent in writing.
◆ 参会对象:
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|